Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV)

PURPOSE: Preventing chemotherapy-induced nausea and vomiting (CINV) is integral to treatment success in patients with cancer. This analysis was undertaken to assess the relative efficacy and safety of palonosetron versus older 5HT(3) RAs in preventing CINV associated with moderately or highly emetog...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartzberg, Lee, Barbour, Sally Y., Morrow, Gary R., Ballinari, Gianluca, Thorn, Michael D., Cox, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889920/
https://www.ncbi.nlm.nih.gov/pubmed/24141698
http://dx.doi.org/10.1007/s00520-013-1999-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889920/
https://www.ncbi.nlm.nih.gov/pubmed/24141698
http://dx.doi.org/10.1007/s00520-013-1999-9

Ejemplares similares